세계 의약품 등급 유당 시장 : 점유율, 규모, 동향, 산업 분석 보고서 - 유형별, 지역별, 부문별 예측(2024년-2032년)

The global pharmaceutical grade lactose market size is expected to reach USD 3.21 billion by 2032, according to a new study by Polaris Market Research. The report "Pharmaceutical Grade Lactose Market Share, Size, Trends, Industry Analysis Report, By Type (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray Dried Lactose), By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Novel medicines, alternatively known as new or innovative medicines, are pharmaceutical products that are recently developed and distinctively differ from existing medications. These groundbreaking medicines typically involve significant advancements or breakthroughs in medical science and technology. Examples of novel medicines encompass biologics, new chemical entities (NCE), targeted therapies, gene therapies, & immunotherapies. The development of these innovative medicines is propelled by extensive research and development (R&D) efforts undertaken by various drug manufacturing companies globally.

In the realm of pharmaceutical formulations, the inclusion of various excipients is common, and manufacturers are presented with a variety of options. In this landscape, alternative excipients that provide similar functionality and cost advantages may emerge as competitors to a specific product, potentially impacting its market demand.

For instance, EMDEX, as highlighted by the JRS PHARMA. This excipient exhibits promising potential as a feasible alternative to spray-dried lactose, showcasing comparable characteristics concerning powder and tableting properties. This competition among excipients underscores the dynamic nature of the pharmaceutical industry, where the selection of excipients plays a crucial role in formulation development.

European Union (EU) has instituted regulations and incentives to stimulate the growth of the industry and attract investments. As a result, these factors collectively contribute to the expansion, resulting in an augmented demand for products, especially those widely employed in tablets and capsules.

The industry is marked by fierce competition, with numerous companies actively seeking to capture market share and cater to a diverse range of end-users on a global scale. To gain a competitive advantage in this dynamic landscape, it becomes crucial for companies to concentrate on strategic initiatives such as product launches, expansion efforts, and research and development activities.

Leading manufacturers in the market are driven to achieve a heightened level of dominance by engaging in various initiatives that enhance their product offerings, extend their market reach, and foster innovation. This competitive environment underscores the importance of continuous efforts and strategic maneuvers to thrive in the pharmaceutical-grade lactose sector.

Pharmaceutical Grade Lactose Market Report Highlights

The crystalline monohydrate lactose segment dominated the market; this can be attributed to its elevated purity, solubility, and flow properties, to guarantee the safety and effectiveness of their pharmaceutical products.

Asia Pacific will grow rapidly, primarily due to a rise in disposable income, high milk production in the region, and positive support from the government in dairy processing

North America dominated the market on account of the presence of players in the region, well developed pharmaceutical industry, and innovations in the sector

The global players include ARMOR PROTEINES, BASF, Charotar Casein, DFE Pharma, Fengchen, Alpavit, Kavya Pharma, Lactalis Ingredients, Lactose (India), MEGGLE, Friesland Campina, & Surfachem.

Polaris Market Research has segmented the pharmaceutical grade lactose market report based on type, and region:

Pharmaceutical Grade Lactose, Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Crystalline Monohydrate Lactose
• Inhalation Lactose
• Granulated Lactose
• Spray-dried Lactose
• Other Types

Pharmaceutical Grade Lactose, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Pharmaceutical Grade Lactose Market Insights

• 4.1. Pharmaceutical Grade Lactose Market - Industry Snapshot
• 4.2. Pharmaceutical Grade Lactose Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising healthcare spending fuels optimism in pharmaceutical industry growth
    • 4.2.1.2. Expanding biopharmaceutical manufacturing and protein drug formulations
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Limited availability of high-quality raw materials
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. Value Chain Analysis
• 4.6. Pharmaceutical Grade Lactose Industry trends
• 4.7. COVID-19 Impact Analysis

5. Global Pharmaceutical Grade Lactose Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
• 5.3. Crystalline Monohydrate Lactose
  • 5.3.1. Global Pharmaceutical Grade Lactose Market, by Crystalline Monohydrate Lactose, by Region, 2019-2032 (USD Billion)
• 5.4. Inhalation Lactose
  • 5.4.1. Global Pharmaceutical Grade Lactose Market, by Inhalation Lactose, by Region, 2019-2032 (USD Billion)
• 5.5. Granulated Lactose
  • 5.5.1. Global Pharmaceutical Grade Lactose Market, by Granulated Lactose, by Region, 2019-2032 (USD Billion)
• 5.6. Spray-dried Lactose
  • 5.6.1. Global Pharmaceutical Grade Lactose Market, by Spray-dried Lactose, by Region, 2019-2032 (USD Billion)
• 5.7. Others
  • 5.7.1. Global Pharmaceutical Grade Lactose Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Pharmaceutical Grade Lactose Market, by Geography

• 6.1. Key findings
• 6.2. Introduction
  • 6.2.1. Pharmaceutical Grade Lactose Market Assessment, By Geography, 2019-2032 (USD Billion)
• 6.3. Pharmaceutical Grade Lactose Market - North America
  • 6.3.1. North America: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.3.2. Pharmaceutical Grade Lactose Market - U.S.
    • 6.3.2.1. U.S.: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.3.3. Pharmaceutical Grade Lactose Market - Canada
    • 6.3.3.1. Canada: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
• 6.4. Pharmaceutical Grade Lactose Market - Europe
  • 6.4.1. Europe: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.4.2. Pharmaceutical Grade Lactose Market - UK
    • 6.4.2.1. UK: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.4.3. Pharmaceutical Grade Lactose Market - France
    • 6.4.3.1. France: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.4.4. Pharmaceutical Grade Lactose Market - Germany
    • 6.4.4.1. Germany: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.4.5. Pharmaceutical Grade Lactose Market - Italy
    • 6.4.5.1. Italy: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.4.6. Pharmaceutical Grade Lactose Market - Spain
    • 6.4.6.1. Spain: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.4.7. Pharmaceutical Grade Lactose Market - Netherlands
    • 6.4.7.1. Netherlands: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.4.8. Pharmaceutical Grade Lactose Market - Austria
    • 6.4.8.1. Austria: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
• 6.5. Pharmaceutical Grade Lactose Market - Asia Pacific
  • 6.5.1. Asia Pacific: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.5.2. Pharmaceutical Grade Lactose Market - China
    • 6.5.2.1. China: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.5.3. Pharmaceutical Grade Lactose Market - India
    • 6.5.3.1. India: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.5.4. Pharmaceutical Grade Lactose Market - Malaysia
    • 6.5.4.1. Malaysia: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.5.5. Pharmaceutical Grade Lactose Market - Japan
    • 6.5.5.1. Japan: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.5.6. Pharmaceutical Grade Lactose Market - Indonesia
    • 6.5.6.1. Indonesia: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.5.7. Pharmaceutical Grade Lactose Market - South Korea
    • 6.5.7.1. South Korea: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
• 6.6. Pharmaceutical Grade Lactose Market - Middle East & Africa
  • 6.6.1. Middle East & Africa: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.6.2. Pharmaceutical Grade Lactose Market - Saudi Arabia
    • 6.6.2.1. Saudi Arabia: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.6.3. Pharmaceutical Grade Lactose Market - UAE
    • 6.6.3.1. UAE: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.6.4. Pharmaceutical Grade Lactose Market - Israel
    • 6.6.4.1. Israel: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.6.5. Pharmaceutical Grade Lactose Market - South Africa
    • 6.6.5.1. South Africa: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
• 6.7. Pharmaceutical Grade Lactose Market - Latin America
  • 6.7.1. Latin America: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.7.2. Pharmaceutical Grade Lactose Market - Mexico
    • 6.7.2.1. Mexico: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.7.3. Pharmaceutical Grade Lactose Market - Brazil
    • 6.7.3.1. Brazil: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)
  • 6.7.4. Pharmaceutical Grade Lactose Market - Argentina
    • 6.7.4.1. Argentina: Pharmaceutical Grade Lactose Market, by Type, 2019-2032 (USD Billion)

7. Competitive Landscape

• 7.1. Expansion and Acquisition Analysis
  • 7.1.1. Expansion
  • 7.1.2. Acquisitions
• 7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

• 8.1. Alpavit
  • 8.1.1. Company Overview
  • 8.1.2. Financial Performance
  • 8.1.3. Product Benchmarking
  • 8.1.4. Recent Development
• 8.2. ARMOR PROTEINES
  • 8.2.1. Company Overview
  • 8.2.2. Financial Performance
  • 8.2.3. Product Benchmarking
  • 8.2.4. Recent Development
• 8.3. BASF Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Financial Performance
  • 8.3.3. Product Benchmarking
  • 8.3.4. Recent Development
• 8.4. Charotar Casein Company
  • 8.4.1. Company Overview
  • 8.4.2. Financial Performance
  • 8.4.3. Product Benchmarking
  • 8.4.4. Recent Development
• 8.5. DFE Pharma
  • 8.5.1. Company Overview
  • 8.5.2. Financial Performance
  • 8.5.3. Product Benchmarking
  • 8.5.4. Recent Development
• 8.6. Fengchen Group Co., Ltd.
  • 8.6.1. Company Overview
  • 8.6.2. Financial Performance
  • 8.6.3. Product Benchmarking
  • 8.6.4. Recent Development
• 8.7. FrieslandCampina
  • 8.7.1. Company Overview
  • 8.7.2. Financial Performance
  • 8.7.3. Product Benchmarking
  • 8.7.4. Recent Development
• 8.8. Kavya Pharma
  • 8.8.1. Company Overview
  • 8.8.2. Financial Performance
  • 8.8.3. Product Benchmarking
  • 8.8.4. Recent Development
• 8.9. Kerry Group plc
  • 8.9.1. Company Overview
  • 8.9.2. Financial Performance
  • 8.9.3. Product Benchmarking
  • 8.9.4. Recent Development
• 8.10. Lactalis Ingredients
  • 8.10.1. Company Overview
  • 8.10.2. Financial Performance
  • 8.10.3. Product Benchmarking
  • 8.10.4. Recent Development
• 8.11. Lactose (India) Limited
  • 8.11.1. Company Overview
  • 8.11.2. Financial Performance
  • 8.11.3. Product Benchmarking
  • 8.11.4. Recent Development
• 8.12. MEGGLE GmbH & Co. KG
  • 8.12.1. Company Overview
  • 8.12.2. Financial Performance
  • 8.12.3. Product Benchmarking
  • 8.12.4. Recent Development
• 8.13. Surfachem Group Ltd
  • 8.13.1. Company Overview
  • 8.13.2. Financial Performance
  • 8.13.3. Product Benchmarking
  • 8.13.4. Recent Development